Other studies identifying a contributory role for MIF in MDSC-dependent tumor progression include a finding that an IG-CDR-based peptide that disrupts MIF-CD74 signaling is sufficient to reduce M-MDSC accumulation in metastatic melanoma lesions (104). Here, CD74 is linked to neoplasm.